Ketyruda

SABCS: Merck's Keytruda notches win in triple-negative breast cancer as Roche's Tecentriq falls short
Fierce Pharma
Thu, 12/12/19 - 11:12 am
Merck
Ketyruda
Roche
Tecentriq
immuno-oncology
SABCS
triple-negative breast cancer